Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp, OmniSeq Sign Distribution Deal

NEW YORK (GenomeWeb) – OmniSeq and Laboratory Corporation of America have signed an exclusive distribution agreement for OmniSeq's immune profiling and pan-cancer next-generation sequencing tests.

In addition, LabCorp will also participate in OmniSeq's Series B financing round, the proceeds of which will be used to conduct ongoing retrospective and prospective clinical trials. LabCorp Diagnostics CSO Marcia Eisenberg will join OmniSeq’s board of directors.

OmniSeq is a molecular diagnostics subsidiary of the Roswell Park Cancer Institute. Both its Immune Report Card test and OmniSeq Comprehensive test have received approval from New York State's Clinical Laboratory Evaluation Program. The Immune Report Card assay is designed to help oncologists make treatment decisions regarding immune checkpoint inhibitors by analyzing microsatellite instability, mutational burden, and performing RNA-seq. OmniSeq Comprehensive is a 144-gene pan-cancer NGS assay designed to guide treatment decisions.

Under the terms of the agreement with LabCorp, the assays will be performed by OmniSeq and offered in the US through Integrated Oncology and globally through Covance Drug Development.

"By combining OmniSeq's technology with LabCorp's unmatched companion diagnostics expertise, we will bring advances in precision medicine to many more physicians and biopharmaceutical partners," Eisenberg said in a statement.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.